GATC Subsidiary LifeCodexx to Develop Prenatal Dx Based on Next-Gen Sequencing

The company is currently validating its method for an undisclosed test using clinical samples.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.